Edit Entry | Edit CV

Mary F. Brunette, MD

Professor of Psychiatry
Professor of Community and Family Medicine
Professor of The Dartmouth Institute

Additional Titles/Positions/Affiliations
Medical Director, Bureau of Mental Health Services, NH Dept of Health and Human Services
Co-Director, Northern New England Post-Doctoral Primary Care Research Training Program
Co-DIrector, Community Engaged Research Core, Dartmouth SYNERGY, CTSA
Chairman, NH DHHS Committee for the Protection of Human Subjects
Co-Investigator, Ctr for Technology & Behavioral Health

Community and Family Medicine
The Dartmouth Institute

Lewis & Clark College, BA 1985
Oregon Health Sciences University, MD 1991

C. Everett Koop Institute at Dartmouth
Norris Cotton Cancer Center
Psychopharmacology Research Group

Academic Analytics
View Profile

Contact Information

Department of Psychiatry, Dartmouth-Hitchcock
Center for Technology and Behavioral Health
46 Centerra Parkway, level 2
Lebanon NH 0

Phone: 603-646-7019
Email: Mary.f.brunette@dartmouth.edu

Assistant: Brian Goodness
Asst. Email: Brian.d.goodness@dartmouth.edu

Professional Interests

The goal of my research is to better understand the causes of addiction in vulnerable, complex populations, and to develop effective and disseminable treatment interventions for addiction in these groups by using a translational science approach that includes basic science, patient-oriented treatment and population-based studies.

In addition, I am engaged with public mental health administration in which I advance improvements in care for people with serious mental illness and multiple comorbidities.

Grant Information

ProHealth NH: New Hampshire Partnerships to Improve Health & Wellness for Young People with SED and SMI

1H79SM080245-01 Substance Abuse and Mental Health Administration

Cannabis, schizophrenia and reward: Self-Medication and agonist

1R01DA034699-01 National Institute on Drug Abuse

Comparative effectiveness of integrated vs. referral-based care for pregnant women with opioid use disorder (Lord and Goodman, Multiple PIs)

MAT-2017C2-7717 PCORI

Stemming the Tide: The Role of Payment and Delivery System Reform in
Combating the Opioid Epidemic (Colla PI)

4R01-DA049757-01A1 National Institute on Drug Abuse

Mentoring Information

I currently lead several large studies, including a trial using functional magnetic resonance imaging to assess the impact of cannabis on brain reward function in schizophrenia, and the implementation of integrated primary care and community mental health.

I am trained as an “Entering Mentoring” Facilitator, with a goal of increasing quality, equity and inclusion in science mentoring. I mentor research trainees on a variety of projects across the translational range - from a secondary analyses describing substance use in young adults with multiple morbidities, to a literature review of impact of cannabis on psychosis, to usability testing of apps for the treatment of addiction, and a qualitative study of a learning community to support statewide implementation of clinical services.

Selected Publications


Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2-4.
Brunette MF, Halenar MJ, Edwards KC, Taylor KA, Emond JA, Tanski SE, Woloshin S, Paulin LM, Hyland A, Lauten K, Mahoney M, Blanco C, Borek N, DaSilva LC, Gardner LD, Kimmel HL, Sargent JD
BMJ Open Respir Res. 2023 Feb;10(1) doi: 10.1136/bmjresp-2021-001187.
PMID: 36750276

Promoting community stakeholder engagement in research on treatment for pregnant women with opioid use disorder.
Johnson DJ, Brunette MF, Goodman DJ, Adams M, Bryer C, Doherty JR, Flanagan V, Frew JR, Mullins S, Sheehan F, Tobar-Santamaria A, Whitney S, Lord S
J Comp Eff Res. 2022 Oct;11(15):1085-1094. doi: 10.2217/cer-2022-0090. Epub 2022 Sep 1.
PMID: 36047333

Outcomes During and After Early Intervention Services for First-Episode Psychosis: Results Over 5 Years From the RAISE-ETP Site-Randomized Trial.
Robinson DG, Schooler NR, Marcy P, Gibbons RD, Hendricks Brown C, John M, Mueser KT, Penn DL, Rosenheck RA, Addington J, Brunette MF, Correll CU, Estroff SE, Mayer-Kalos PS, Gottlieb JD, Glynn SM, Lynde DW, Gingerich S, Pipes R, Miller AL, Severe JB, Kane JM
Schizophr Bull. 2022 Sep 1;48(5):1021-1031. doi: 10.1093/schbul/sbac053.
PMID: 35689478

Health status of young adults with serious mental illness enrolled in integrated care.
Brunette MF, Gowarty MA, Gaughan-Maher AE, Pratt SI, Aschbrenner KA, Considine-Sweeny S, Elliott J, Almeida M, L'Esperance AM
Early Interv Psychiatry. 2023 Feb;17(2):167-176. doi: 10.1111/eip.13302. Epub 2022 Jun 7.
PMID: 35672918

Relapse prevention through health technology program reduces hospitalization in schizophrenia.
Homan P, Schooler NR, Brunette MF, Rotondi A, Ben-Zeev D, Gottlieb JD, Mueser KT, Achtyes ED, Gingerich S, Marcy P, Meyer-Kalos P, Hauser M, John M, Robinson DG, Kane JM
Psychol Med. 2022 May 30;:1-7. doi: 10.1017/S0033291722000794. Epub 2022 May 30.
PMID: 35634965

Innovations in Care Delivery for Patients With Serious Mental Illness Among Accountable Care Organizations.
Newton H, Busch SH, Brunette MF, Maust DT, O'Malley AJ, Meara E
Psychiatr Serv. 2022 Aug 1;73(8):889-896. doi: 10.1176/appi.ps.202000484. Epub 2022 Apr 5.
PMID: 35378992

E-Cigarette Provision to Promote Switching in Cigarette Smokers With Serious Mental Illness-A Randomized Trial.
Pratt SI, Ferron JC, Brunette MF, Santos M, Sargent J, Xie H
Nicotine Tob Res. 2022 Aug 6;24(9):1405-1412. doi: 10.1093/ntr/ntac082.
PMID: 35363874

Treatment Interruptions and Telemedicine Utilization in Serious Mental Illness: Retrospective Longitudinal Claims Analysis.
Ainslie M, Brunette MF, Capozzoli M
JMIR Ment Health. 2022 Mar 21;9(3):e33092. doi: 10.2196/33092. Epub 2022 Mar 21.
PMID: 35311673

Characteristics of and reasons for electronic cigarette use among adult smokers with schizophrenia/schizoaffective disorder.
Wong JA, Pratt SI, Ferron JC, Gowarty M, Brunette MF
Ann Clin Psychiatry. 2022 Feb;34(1):89-96. doi: 10.12788/acp.0050.
PMID: 35166668

Validation of an Index for Functionally Important Respiratory Symptoms among Adults in the Nationally Representative Population Assessment of Tobacco and Health Study, 2014-2016.
Halenar MJ, Sargent JD, Edwards KC, Woloshin S, Schwartz L, Emond J, Tanski S, Pierce JP, Taylor KA, Lauten K, Goniewicz ML, Niaura R, Anic G, Chen Y, Callahan-Lyon P, Gardner LD, Thekkudan T, Borek N, Kimmel HL, Cummings KM, Hyland A, Brunette MF
Int J Environ Res Public Health. 2021 Sep 14;18(18) doi: 10.3390/ijerph18189688. Epub 2021 Sep 14.
PMID: 34574610

View more publications on PubMed